← Back to Clinical Trials
Recruiting NCT07466290

L-serine and Strength Training in the Elderly

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Brain Health
Sponsor University of Vienna
Study Type INTERVENTIONAL
Phase N/A
Enrollment 126
Sex ALL
Min Age 65 Years
Max Age 85 Years
Start Date 2026-03
Completion 2027-12
Interventions
Strength trainingL-serine supplementationControl (cornstarch)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study investigates whether taking the amino acid L-serine, either alone or in combination with targeted strength training, can have a positive effect on mental performance, brain function, and physical fitness in older people. Healthy, independent women and men aged 65 to 85 are eligible to participate. Participants will be randomly assigned to one of three groups: placebo, L-serine, or L-serine combined with strength training. Cognitive tests, physical performance tests, and blood and brain tests will be conducted over a period of 48 weeks. The aim is to gain a better understanding of how nutrition and exercise can contribute to healthy aging.

Eligibility Criteria

Inclusion Criteria: * Men and women between the ages of 65 and 85 * Mini-Mental-State \>23 * Independently mobile, without aids (walker, cane, etc.) Exclusion Criteria: * Chronic diseases that contraindicate medical training therapy * Regular strength training (\>1x/week) in the last 6 months before confinement * Frailty Index ≥ 3 * Lack of written consent to test physical performance * Regular use of Cortison-containing medications or Antibiotika * MR-specific exclusion criteria: claustrophobia, metal equipment or other magnetic Material in or on the body * Non-compliance with the study protocol: \<70% of the planned L-serine administration, \<70% of the strength training

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}